Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation - 22/08/11
Résumé |
Objective |
The purpose of this study was to compare neonatal outcomes of pregnancies with preeclampsia or gestational hypertension with those of normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation separately.
Study Design |
Secondary analysis of neonatal outcomes by week of delivery between 35 and 37 weeks 6 days of gestation to 4293 nulliparous women who were enrolled in a multicenter National Institute for Child Health and Human Development study. Outcomes included the percentage of neonatal intensive care unit admission, duration of neonatal hospitalization, and neonatal complications.
Results |
As compared with normotensive pregnancies, hypertensive pregnancies that delivered at 35 and 36 weeks of gestation had higher rates of small for gestational age births (17.9% vs 1.7% [P < .05] and 33.3% vs 12.2% [P < .01], respectively) and neonatal intensive care unit admission (57.1% vs 34.5% [P < .05] and 33.3% vs 10.7% [P < .001]). The rate of neonatal intensive care unit admission (25.6% vs 8.7%; P < .001) and duration of neonatal stay (3.9 vs 2.0 days; P < .001) were greater in hypertensive pregnancies that delivered at 37 weeks of gestation.These differences were observed largely in women whose condition required labor induction, regardless of the severity of the hypertensive disease.
Conclusion |
Pregnancies with preeclampsia or gestational hypertension that delivered between 35 and 37 weeks of gestation had higher rates of neonatal intensive care unit admission, small for gestational age, and longer neonatal stay than normotensive pregnancies, regardless of the severity of the hypertensive disease.
Le texte complet de cet article est disponible en PDF.Key words : labor induction, late preterm birth, neonatal outcome, preeclampsia
Plan
| Reprints not available from the authors. |
|
| Supported by funds from the intramural research program of the National Institute of Child Health and Human Development, National Institutes of Health. The Calcium for Preeclampsia Prevention (CPEP) trial was supported by contracts (N01-HD-1-3121, -3122, -3123, -3124, -3125, and -3126; N01-HD-3154; and N01-HD-5-3246) with the National Institute of Child Health and Human Development, with cofunding from the National Heart, Lung, and Blood Institute. |
|
| Cite this article as: Habli M, Levine RJ, Qian C, Sibai G. Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. Am J Obstet Gynecol 2007;197:406.e1-406.e7. |
Vol 197 - N° 4
P. 406.e1-406.e7 - octobre 2007 Retour au numéro
Article précédent
- Level of glycemic control and pregnancy outcome in type 1 diabetes: a comparison between multiple daily insulin injections and continuous subcutaneous insulin infusions
- Rony Chen, Avi Ben-Haroush, Alina Weissmann-Brenner, Nir Melamed, Moshe Hod, Yariv Yogev
- A population study of the contribution of medical comorbidity to the risk of prematurity in blacks
- Deborah B. Ehrenthal, Claudine Jurkovitz, Matthew Hoffman, Charlan Kroelinger, William Weintraub
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?